DNA Sequencing Cost | Genetic Disease Screening | Cancer Genomic Testing in 2025 Genetic disease screening is rapidly transforming healthcare, offering unprecedented insights into individual health and disease predisposition. In 2025, as technology continues its relentless advance, understanding the DNA sequencing cost becomes paramount for B2B buyers, analysts, and procurement professionals navigating this complex yet critical market. The ability to accurately predict, prevent, and personalize treatments hinges on accessible and affordable genomic data. This year, the intersection of technological innovation and market demand is pushing the boundaries of what’s possible in genetic diagnostics. How will these advancements impact strategic decisions for healthcare providers and research institutions in the coming year? What is DNA Sequencing Cost and Why It Matters in 2025 DNA sequencing cost refers to the expenses associated with determining the precise order of nucleotides wi...